EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology

Barbara Morone, Giovanna Grimaldi

Expert Reviews in Molecular Medicine · 2024

DOI: 10.1017/erm.2024.13 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, 2024. Verfasst von Barbara Morone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Endocrinology and Experimental Oncology, National Research Council, Via Pietro Castellino 111, Napoli, Italy. Hauptthemen laut MEDLINE: Neoplasms, ADP-Ribosylation, Signal Transduction, Interferons. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADP-ribosyltransferases of the PARP family encompass a group of enzymes with variegated regulatory functions in cells, ranging from DNA damage repair to the control of cell-cycle progression and immune response. Over the years, this knowledge has led to the use of PARP1/2 inhibitors as mainstay pharmaceutical strategies for the treatment of ovarian, pancreatic, prostate and breast cancers, holding mutations in genes encoding for proteins involved in the DNA repair mechanisms (synthetic lethality). Meanwhile, the last decade has witnessed significant progress in comprehending cellular pathways regulated by mono-ADP-ribosylation, with a huge effort in the development of novel selective compounds to inhibit those PARPs endowed with mono-ADP-ribosylation activity. This review focuses on the progress achieved in the cancer field, delving into most recent findings regarding the role of a subset of enzymes – the interferon-stimulated PARPs – in cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsADP-RibosylationSignal TransductionInterferonsPoly(ADP-ribose) PolymerasesPoly(ADP-ribose) Polymerase InhibitorsHumansAnimalsDNA Repair

Stichwörter der Autor:innen

PARP inhibitorsPARPscancer-targeted therapyinterferon-signallingmono-ADP-ribosylation

Substanzen

InterferonsPoly(ADP-ribose) PolymerasesPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Institute for Endocrinology and Experimental Oncology, National Research Council, Via Pietro Castellino 111, Napoli, Italy.

Zitieren

APA

Morone, B., & Grimaldi, G. (2024). PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/erm.2024.13

Vancouver

Morone B, Grimaldi G. PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology. Expert Reviews in Molecular Medicine. 2024. doi:10.1017/erm.2024.13

BibTeX
@article{Morone2024,
  author = {Morone, Barbara and Grimaldi, Giovanna},
  title = {PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology},
  journal = {Expert Reviews in Molecular Medicine},
  year = {2024},
  doi = {10.1017/erm.2024.13}
}
Kostenlos starten →